AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
Log in

NASDAQ:OMEROmeros News Headlines

$14.60
-0.31 (-2.08 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$14.53
Now: $14.60
$14.89
50-Day Range
$14.09
MA: $14.98
$15.72
52-Week Range
$8.50
Now: $14.60
$20.92
Volume309,800 shs
Average Volume640,288 shs
Market Capitalization$795.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.86

Headlines

Omeros (NASDAQ OMER) News Headlines

Source:
DateHeadline
Omeros Co. (NASDAQ:OMER) Expected to Earn FY2021 Earnings of ($2.03) Per ShareOmeros Co. (NASDAQ:OMER) Expected to Earn FY2021 Earnings of ($2.03) Per Share
www.americanbankingnews.com - July 3 at 7:09 AM
Hedge Funds Are Buying Omeros Corporation (OMER) - Yahoo FinanceHedge Funds Are Buying Omeros Corporation (OMER) - Yahoo Finance
finance.yahoo.com - June 24 at 5:06 PM
Hedge Funds Are Buying Omeros Corporation (OMER)Hedge Funds Are Buying Omeros Corporation (OMER)
finance.yahoo.com - June 24 at 5:06 PM
Omeros Co. (NASDAQ:OMER) Expected to Announce Quarterly Sales of $18.12 MillionOmeros Co. (NASDAQ:OMER) Expected to Announce Quarterly Sales of $18.12 Million
www.americanbankingnews.com - June 20 at 2:59 AM
Omeros Co. (NASDAQ:OMER) Receives Average Recommendation of "Hold" from BrokeragesOmeros Co. (NASDAQ:OMER) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - June 19 at 12:37 PM
 Analysts Expect Omeros Co. (NASDAQ:OMER) Will Announce Earnings of -$0.54 Per Share Analysts Expect Omeros Co. (NASDAQ:OMER) Will Announce Earnings of -$0.54 Per Share
www.americanbankingnews.com - June 18 at 3:36 PM
Omeros Narsoplimab Pivotal Trial Data Shared in Oral Presentation at Annual European Hematology Association Congress - Business WireOmeros' Narsoplimab Pivotal Trial Data Shared in Oral Presentation at Annual European Hematology Association Congress - Business Wire
www.businesswire.com - June 12 at 9:34 AM
Omeros’ Narsoplimab Pivotal Trial Data Shared in Oral Presentation at Annual European Hematology Association CongressOmeros’ Narsoplimab Pivotal Trial Data Shared in Oral Presentation at Annual European Hematology Association Congress
finance.yahoo.com - June 12 at 9:34 AM
Q3 2020 EPS Estimates for Omeros Co. (NASDAQ:OMER) Lowered by WedbushQ3 2020 EPS Estimates for Omeros Co. (NASDAQ:OMER) Lowered by Wedbush
www.americanbankingnews.com - June 12 at 6:32 AM
Omeros Narsoplimab Pivotal Trial Data to be Shared as an Oral Presentation at Annual European Hematology Association Congress - Business WireOmeros' Narsoplimab Pivotal Trial Data to be Shared as an Oral Presentation at Annual European Hematology Association Congress - Business Wire
www.businesswire.com - June 11 at 1:23 PM
Omeros’ Narsoplimab Pivotal Trial Data to be Shared as an Oral Presentation at Annual European Hematology Association CongressOmeros’ Narsoplimab Pivotal Trial Data to be Shared as an Oral Presentation at Annual European Hematology Association Congress
finance.yahoo.com - June 11 at 1:23 PM
Omeros (OMER) Hold Rating Reiterated at WedbushOmeros' (OMER) Hold Rating Reiterated at Wedbush
www.marketbeat.com - June 10 at 3:38 AM
IPO Launch: Calliditas Therapeutics Seeks $75 Million In US IPO - TheStreetIPO Launch: Calliditas Therapeutics Seeks $75 Million In US IPO - TheStreet
www.thestreet.com - June 1 at 2:02 PM
Omeros Gets Technical Rating Upgrade, Relative Strength Line Moves Up To 75Omeros Gets Technical Rating Upgrade, Relative Strength Line Moves Up To 75
finance.yahoo.com - May 26 at 7:54 PM
Omeros Corporation Announces Presentation of Narsoplimab Pivotal Trial Data at Upcoming European Hematology Association Annual Congress - Yahoo FinanceOmeros Corporation Announces Presentation of Narsoplimab Pivotal Trial Data at Upcoming European Hematology Association Annual Congress - Yahoo Finance
finance.yahoo.com - May 14 at 1:25 PM
Omeros: Some Concerns Remain... As Do Opportunities - Seeking AlphaOmeros: Some Concerns Remain... As Do Opportunities - Seeking Alpha
seekingalpha.com - May 14 at 1:25 PM
Omeros Corporation Announces Presentation of Narsoplimab Pivotal Trial Data at Upcoming European Hematology Association Annual CongressOmeros Corporation Announces Presentation of Narsoplimab Pivotal Trial Data at Upcoming European Hematology Association Annual Congress
www.businesswire.com - May 14 at 9:19 AM
Edited Transcript of OMER earnings conference call or presentation 11-May-20 8:30pm GMT - Yahoo FinanceEdited Transcript of OMER earnings conference call or presentation 11-May-20 8:30pm GMT - Yahoo Finance
finance.yahoo.com - May 12 at 3:52 PM
Omeros (OMER) Q1 2020 Earnings Call Transcript - Motley FoolOmeros (OMER) Q1 2020 Earnings Call Transcript - Motley Fool
www.fool.com - May 12 at 3:52 PM
BRIEF-Omeros Reports Q1 Loss Per Share $0.53BRIEF-Omeros Reports Q1 Loss Per Share $0.53
www.reuters.com - May 12 at 9:27 AM
Omeros Corporation (OMER) CEO Greg Demopulos on Q1 2020 Results - Earnings Call TranscriptOmeros Corporation (OMER) CEO Greg Demopulos on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 9:27 AM
Omeros (OMER) Q1 2020 Earnings Call TranscriptOmeros (OMER) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 12 at 9:27 AM
Edited Transcript of OMER earnings conference call or presentation 11-May-20 8:30pm GMTEdited Transcript of OMER earnings conference call or presentation 11-May-20 8:30pm GMT
finance.yahoo.com - May 12 at 9:27 AM
Omeros EPS misses by $0.07, misses on revenue - Seeking AlphaOmeros EPS misses by $0.07, misses on revenue - Seeking Alpha
seekingalpha.com - May 11 at 6:08 PM
Omeros (OMER) Misses Q1 EPS by 19c, Revenues Miss - StreetInsider.comOmeros (OMER) Misses Q1 EPS by 19c, Revenues Miss - StreetInsider.com
www.streetinsider.com - May 11 at 6:08 PM
Omeros Corporation Reports First Quarter 2020 Financial Results - Business WireOmeros Corporation Reports First Quarter 2020 Financial Results - Business Wire
www.businesswire.com - May 11 at 6:08 PM
Omeros Corporation Reports First Quarter 2020 Financial ResultsOmeros Corporation Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 11 at 6:08 PM
Should You Buy Omeros (OMER) Ahead of Earnings? - Yahoo FinanceShould You Buy Omeros (OMER) Ahead of Earnings? - Yahoo Finance
finance.yahoo.com - May 8 at 4:13 PM
Should You Buy Omeros (OMER) Ahead of Earnings?Should You Buy Omeros (OMER) Ahead of Earnings?
finance.yahoo.com - May 8 at 4:12 PM
Omeros Corporation to Announce First Quarter Financial Results on May 11, 2020 - Yahoo FinanceOmeros Corporation to Announce First Quarter Financial Results on May 11, 2020 - Yahoo Finance
finance.yahoo.com - May 5 at 12:07 PM
Omeros Corporation to Announce First Quarter Financial Results on May 11, 2020Omeros Corporation to Announce First Quarter Financial Results on May 11, 2020
finance.yahoo.com - May 5 at 12:07 PM
InMode (INMD) to Post Q1 Earnings: Whats in the Offing? - Yahoo FinanceInMode (INMD) to Post Q1 Earnings: What's in the Offing? - Yahoo Finance
finance.yahoo.com - May 1 at 6:32 PM
Omeros Corporation: The Thesis Was Playing Out Before COVID-19 Hit - Seeking AlphaOmeros Corporation: The Thesis Was Playing Out Before COVID-19 Hit - Seeking Alpha
seekingalpha.com - March 31 at 9:09 PM
Omeros Tumultuous March - Seeking AlphaOmeros' Tumultuous March - Seeking Alpha
seekingalpha.com - March 20 at 9:24 AM
Edited Transcript of OMER earnings conference call or presentation 2-Mar-20 9:30pm GMTEdited Transcript of OMER earnings conference call or presentation 2-Mar-20 9:30pm GMT
finance.yahoo.com - March 11 at 2:02 PM
Omeros (OMER) Q4 2019 Earnings Call Transcript - Motley FoolOmeros (OMER) Q4 2019 Earnings Call Transcript - Motley Fool
www.fool.com - March 5 at 11:46 AM
Company News for Mar 4, 2020Company News for Mar 4, 2020
finance.yahoo.com - March 4 at 12:38 PM
Stock Alert: Omeros Corp. (OMER) Catches Eye - NasdaqStock Alert: Omeros Corp. (OMER) Catches Eye - Nasdaq
www.nasdaq.com - March 3 at 8:12 PM
Omeros reports narsoplimab data and highlights from CMC meetings; shares up 15% premarket - Seeking AlphaOmeros reports narsoplimab data and highlights from CMC meetings; shares up 15% premarket - Seeking Alpha
seekingalpha.com - March 3 at 3:12 PM
Heres Why Omeros Corporation Stock Rose as Much as 46.5% Today - Motley FoolHere's Why Omeros Corporation Stock Rose as Much as 46.5% Today - Motley Fool
www.fool.com - March 3 at 3:12 PM
15 Stocks Moving In Mondays After-Hours Session - Benzinga15 Stocks Moving In Monday's After-Hours Session - Benzinga
www.benzinga.com - March 3 at 12:06 AM
Omeros Corporation Reports Fourth Quarter and Year-End 2019 Financial Results - Yahoo FinanceOmeros Corporation Reports Fourth Quarter and Year-End 2019 Financial Results - Yahoo Finance
finance.yahoo.com - March 3 at 12:06 AM
Omeros Corporation Reports Fourth Quarter and Year-End 2019 Financial Results - Business WireOmeros Corporation Reports Fourth Quarter and Year-End 2019 Financial Results - Business Wire
www.businesswire.com - March 2 at 7:06 PM
Omeros (OMER) Reports Q4 Loss, Tops Revenue Estimates - Yahoo FinanceOmeros (OMER) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - March 2 at 7:06 PM
Omeros Corporation Reports Updated Results from Narsoplimab HSCT-TMA Clinical Trial and Highlights from Recent Clinical and CMC Meetings with FDAOmeros Corporation Reports Updated Results from Narsoplimab HSCT-TMA Clinical Trial and Highlights from Recent Clinical and CMC Meetings with FDA
finance.yahoo.com - March 2 at 7:06 PM
Omeros Corporation Reports Fourth Quarter and Year-End 2019 Financial ResultsOmeros Corporation Reports Fourth Quarter and Year-End 2019 Financial Results
finance.yahoo.com - March 2 at 7:06 PM
Omeros (OMER) Reports Q4 Loss, Tops Revenue EstimatesOmeros (OMER) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 2 at 7:06 PM
Omeros Corporation to Announce Fourth Quarter and Year-End 2019 Financial Results on March 2, 2020 - Yahoo FinanceOmeros Corporation to Announce Fourth Quarter and Year-End 2019 Financial Results on March 2, 2020 - Yahoo Finance
finance.yahoo.com - February 24 at 12:38 PM
Omeros Corporation to Announce Fourth Quarter and Year-End 2019 Financial Results on March 2, 2020Omeros Corporation to Announce Fourth Quarter and Year-End 2019 Financial Results on March 2, 2020
finance.yahoo.com - February 24 at 7:37 AM
BRIEF-Omeros Corp Says Increased Number Of Its Directors To Nine And Appointed Kurt Zumwalt As A Director - ReutersBRIEF-Omeros Corp Says Increased Number Of Its Directors To Nine And Appointed Kurt Zumwalt As A Director - Reuters
www.reuters.com - February 11 at 10:38 PM
This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.